Impact of Use Frequency of a Mobile Diabetes Management App on Blood Glucose Control: Evaluation Study.

Josep Vehí Jordi Regincós Isern Adrià Parcerisas Remei Calm Ivan Contreras

Published in: JMIR mHealth and uHealth (2019)

A significant reduction in BG was found in all groups, independent of the use frequency of the app. Better outcomes were found for T2DM patients. A significant reduction in LBGI and HBGI was found in all groups, regardless of the use frequency of the app. LBGI and HBGI indices of both groups tend to have similar values after 6 months of app use.

Keyphrases

blood glucose
glycemic control
type diabetes
end stage renal disease
newly diagnosed
ejection fraction
cardiovascular disease
prognostic factors
peritoneal dialysis
metabolic syndrome
adipose tissue
weight loss
patient reported